For several months I have been commenting on job formation – specifically, the lack thereof. Several people have told me I am being too negative and that the economy is really OK. Of course, others ...

What: Oncothyreon is down 30% at 1:30 p.m. EST after announcing updated data from its ongoing trials testing ONT-380 in patients with breast cancer yesterday. So what: From the stock move, you'd think ...

A barrage of post-shutdown data this week has left economists with more questions than answers about the state of the U.S. economy. Unemployment rose to a four-year high in November, inflation ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations, causing significant stock volatility. High trading volumes and sharp stock ...